Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes

British Journal of Cancer

Volumn 79, Issue 1, 1999, Pages 119-130

  Menetrier Caux C ^a   Bain, C ^a   Favrot, M C ^a   Duc, A ^a   Blay, J Y ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Immunosuppression; Interleukin 10; Prostaglandin E2; Renal cell carcinoma; Tumour necrosis factor

Indexed keywords

CD86 ANTIGEN; CYTOKINE ANTIBODY; HLA DR ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INDOMETACIN; INTERLEUKIN 10; MANNOSE RECEPTOR; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MONOCYTE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

BASE SEQUENCE; CARCINOMA, RENAL CELL; CULTURE MEDIA, CONDITIONED; DINOPROSTONE; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERLEUKIN-10; KIDNEY NEOPLASMS; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032889264     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690021     Document Type: Article

References (35)

1. Abrams JS, Roncarolo MG, Yssel H, Andersson U, Gleich GJ and Silver JE (1992) Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol Rev 127: 5-24
2. Alleva DG, Askew D, Burger CJ and Elgert KD (1993) Tumor-induced macrophage Tumor Necrosis Factor-α production suppresses autoreactive T cells. Immunobiology 188: 430-435
3. Bachwich PR, Chensue SW, Larrick JW and Kunkel SL (1986) Tumor necrosis factor α stimulates interleukin-1 and prostaglandin-E2 production in resting macrophages. Biochem Biophys Res Commun 136: 94-101
4. Bain C, Puisieux I, Merrouche Y, Duc A, Colombo MP and Favrot MC (1996) B7.1 gene transduction of human renal-cell-carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells. Int J Cancer 67: 769-776
5. Benjamin D, Knoblock TJ and Dayton MA (1992) Human B cell interleukin-10: B cell lines derived from patients with acquired immunodeficiency syndrome and Burkitt's lymphoma constitutively secrete large quantities of interleukin-10. Blood 80: 1289-1298
6. Blay JY, Burdin N, Rousset F, Lenoir G, Biron P, Philip T, Banchereau J and Favrot MC (1993) Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor. Blood 82: 2169-2174
7. Capsoni F, Minonzio F, Ongari AM, Carbonelli V, Galli A and Zanussi C (1995) IL-10 up-regulates human monocyte phagocytosis in the presence of IL-4 and IFNγ. J Leukoc Biol 58: 351-358
8. Cohen PJ, Lotze MT, Roberts JR, Rozenberg S and Jaffé ES (1987) The immunopathology of sequential tumor biopsies in patients treated with IL2: correlation of response with T cell infiltration and HLA-DR expression. Am J Pathol 129: 208-216
9. Combaret V, Wang Q, Favrot MC, Thiesse P, Philip I, Bouffet E, Bailly C, Bouvier R, Chauvin F, Zucker JM, Bernard JL, Lenoir G and Philip T (1989) Clinical value of N-myc oncogene amplification in 52 patients with neuroblastoma included in recent therapeutic protocols. Eur J Clin Oncol 24: 1607-1612
10. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG and de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220
11. + T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150: 4754-4765
12. Emilie D, Touitou R, Raphael N, Peuchmaur N, Devergnee O, Coumharas DRJ, Crevon NC, Edelman L, Jouab I and Galanaud P (1992) In vivo production of interleukin-10 by malignant cells in AIDS lymphoma. Eur J Immunol 22: 2937-2942
13. Filgueira L, Zuber M, Merlo A, Caetano V, Schultz E, Harder F, Spagnoli GC and Heberer M (1993) Cytokine gene transcription in renal cell carcinoma. Br J Surg 80: 1322-1325
14. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW and O'Garra A (1991) IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146: 3444-3451
15. Gastl GA, Abrams JS, Nanus DM, Oosterkamp R, Silver J, Liu F, Chen M, Albino AP and Bander NH (1993) Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 55: 96-101
16. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742
17. Hashimoto S, Yanada M, Motoyoshi K and Akagawa KS (1997) Enhancement of macrophage colony stimulating factor induced growth and differentiation of human monocytes by IL-10. Blood 89: 315-321
18. Howard M and O'Garra A (1992) Biological properties of interleukin 10. Immunol Today 12: 198-201
19. 2 enhance peripheral blood lymphocyte IL-10 transcription and protein production. J Immunol 157: 5512-5520
20. Kambayashi T, Alexander R, Fong M and Strassmann G (1995) Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon 26 derived PGE-2 inhibits TNFα release via a mechanism involving IL-10. J Immunol 154: 3383-3390
21. Lehmmann V, Benninghoff B and Droge W (1988) Tumor necrosis factor α induced activation of peritoneal macrophages is regulated by Prostaglandin-E2 and cAMP. J Immunol 141: 587-591
22. Mauerer MJ, Martin DM, Castelli C, Elder E, Leder G, Storkus WJ and Lotze MT (1995) Host immune response in renal cell cancer: interleukin-4 (IL-4) and IL-10 mRNA are frequently detected in freshly collected tumor-infiltrating lymphocytes. Cancer Immunol Immunother 41: 111-121
23. Nakagomi H, Pisa P, Pisa EK, Yamamoto Y, Halapi E, Backlin K, Juhlin C and Kiessling R (1995) Lack of interleukin-2 (IL-2) expression and selective expression of IL-10 mRNA in human renal cell carcinoma. Int J Cancer 63: 366-371
24. Négrier S, Escudier B, Lasset C, Savary J, Chevreau C, Ravaud A, Peny J and Mousseau M (1996) The FNCLCC CRECY trial: interleukin 2 (IL2) + interferon (IFN)-α is the optimal treatment to induce responses in metastatic renal cell carcinoma (MRCC). Proc Am Soc Clin Oncol 15: 248 (abstract)
25. Oosterwijk E, Ruiter DJ, Hoedemaeker PJ, Pauwels EKJ, Jonas U, Zwartendijk J and Warnaar SO (1986) Monoclonal antibody G-250 recognizes a determinant present in renal cell carcinoma and absent from normal kidney. Int J Cancer 38: 489-494
26. Pisa P, Halapi E, Pisa EK, Gerdin E, Hising C, Bucht A and Kiessling R (1992) Selective expression of interleukin-10, interferon γ, and granulocyte-macrophage colony stimulating factor in ovarian cancer biopsies. Proc Natl Acad Sci (USA) 89: 7708-7712
27. Rosenberg SA, White DE, Lotze MT, Yang JC, Linehan WM, Seipp C, Calabro S, Karp SE, Sherry RM, Steinberg S and White DE (1989) Combination therapy with interleukin-2 and α interferon for the treatment of patients with advanced cancer. J Clin Oncol 7: 1863-1874
28. Rubin JT, Elwood LJ, Rosenberg SA and Lotze MT (1989) Immunohistochemical correlates of response to recombinant Interleukin-2-based immunotherapy in humans. Cancer Res 49: 7086-7092
29. Sallusto F and Lanzavecchia A (1994) Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulecyte/macrophage colony stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor α. J Exp Med 179: 1109-1118
30. Sallusto F, Cella M, Danieli C and Lanzavecchia A (1995) Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down regulation by cytokines and bacterial products. J Exp Med 182: 389-400
31. Taga K, Mostowski H and Tosato G (1993) Human interleukin 10 can directly inhibit T cell growth. Blood 81: 2964-2971
32. Voorzanger N, Touitou R, Delecluse HJ, Rousset F, Joab I, Favrot MC and Blay JY (1996) IL-10 and IL-6 are produced in vivo by non Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res 56: 5499-5505
33. Wang Q, Redovan C, Tubbs R, Olencki T, Klein E, Kudoh S, Finke J and Bukowski RM (1995) Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor infiltrating lymphocytes. Int J Cancer 61: 780-785
34. Wanidworanum C and Strober W (1993) Predominant role of tumor necrosis factor-α in human monocyte IL-10 synthesis. J Immunol 151: 6853-6861
35. Watts C (1997) Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15: 821-850